IV Molecular Cytopathology Focus on Next Generation Sequencing in Cytopathology
|
|
|
- Eric Holland
- 10 years ago
- Views:
Transcription
1 Napoli 4 dicembre 2015 Università Degli Studi di Napoli Federico II Dipartimento di Sanità Pubblica Meeting Director: Giancarlo Troncone Centro Congressi Federico II Via Partenope Napoli IV Molecular Cytopathology Focus on Next Generation Sequencing in Cytopathology
2 Napoli 4 dicembre 2015 Università Degli Studi di Napoli Federico II Dipartimento di Sanità Pubblica Meeting Director: Giancarlo Troncone Centro Congressi Federico II Via Partenope Napoli IV Molecular Cytopathology Focus on Next Generation Sequencing in Cytopathology Until recently, cytological samples were only tested by sequential single-gene mutational tests. Next generation sequencing, matched with multiplex capture of targeted gene regions and analysed by sophisticated bioinformatics tools, enables the simultaneous detection of multiple mutations in multiple genes. By the development of miniaturized technology and of benchtop sequencers it is not unlikely that NGS will soon be adopted for routine molecular diagnostics, including cytological samples. The IV MOLECULAR CYTOPATHOLOGY meeting addresses (1) the most relevant methodological and technical aspects of the NGS analysis workflow and the diverse platforms available; (2) the issues related to daily practice implementation, namely, the cytological sample requirement and the validation procedures; and (3) the opportunities that NGS offers in different fields of cytopathology, to increase mutation detection sensitivity in paucicellular smears and to extend the analysis to a larger number of gene regions.
3 IV Molecular Cytopathology Napoli 4 Dicembre Preliminary Programme h 9.30 Welcome: Gaetano Manfredi Rettore Università degli studi di Napoli Federico II Maria Triassi Direttore Dipartimento Sanità Pubblica Gaetano de Rosa Presidente SIAPEC Ambrogio Fassina (Padova) Cytology Working group SIAPEC h Meeting overview: Giancarlo Troncone (Napoli). Next Generation Cytopathology I Session : h Update on Molecular cytopathology Chairmen: Pio Zeppa (Salerno) Philippe Vielh (Paris) Molecular cytopathology as a diagnostic tool Fernando Schmitt (Luxemburg) Molecular cytopathology as a predictive tool Spasineha Savic (Basel) FISH role in molecular cytopathology II Session: h 12, NGS analysis on cytology Chairmen: Antonio Marchetti (Chieti) Umberto Malapelle (Napoli) How to make NGS working on cytology Salto Tellez Manuel (Belfast) How to validate next generation sequencing Gabriella Fontanini (Pisa) Multitarget assay on cytology: not only NGS.
4 III Session : h 13, Liquid Biopsy Chairmen: Gabriella Fontanini (Pisa) Miguel Angel Molina (Barcellona ) EGFR mutations in circulating tumour DNA Antonio Marchetti (Chieti) Quantification of EGFR mutations in plasma samples of NSCLC patients: clinical implications Lunch (h ) IV Session: Thyroid Molecular Cytopathology ( ,10) Chairmen: Bernardette Biondi (Napoli) Fadda Guido (Roma) Italian consensus on Thyroid cytology and molecular testing Anna Crescenzi (Roma) Thyroid core needle biopsy: taking stock of the situation. Giovanni Tallini (Bologna) Molecular diagnosis of carcinomas of the thyroid gland. Rossi Ester Diana (Roma) Cytological changes and BRAF mutations V Session: Multigene Thyroid Cytopathology (16,30 17,40) Chairmen: Domenico Salvatore (Napoli) Eszlinger Markus (Leipizg) Development of molecular assay on thyroid routine smears Dario de Biase (Bologna) High sensitive BRAF assay on Thyroid cytology Claudio Bellevicine (Napoli) How NGS can refine the risk of malignancy of Indeterminate thyroid FNA Fulvio Basolo (Pisa) Digital gene expression profiling of a series of cytologically indeterminate thyroid nodules Take home message: h
5 Giancarlo Troncone (Napoli)
Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach
Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach Kerry C. Councilman, MD Assistant Professor University of Colorado Denver Goals: BRAF Mutation
BRAF in the diagnostic evaluation of thyroid nodules
Symposium 13 Molecular markers in thyroid cancer: current role in clinical practice BRAF in the diagnostic evaluation of thyroid nodules Laura Fugazzola University of Milan, Italy Papillary carcinoma BRAF
Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare
Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare Maria Chiara Zatelli Sezione di Endocrinologia Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università
Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid
Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_markers_in_fine_needle_aspirates_of_the_thyroid
Craig Hallum Conference Investor Presentation
Craig Hallum Conference Investor Presentation Improving cancer outcomes with groundbreaking precision in molecular testing Paul Kinnon President and CEO Sept 2015 1 Forward-Looking Statements Certain statements
MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15
MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases,
Classificazioni citologiche: verso uno schema internazionale unificato?
Cytology and molecular biology for thyroid nodules diagnos6c categories to clinical ac6ons From Classificazioni citologiche: verso uno schema internazionale unificato? A. Crescenzi Diagnostic categories
Writing Group for the AACE Thyroid Scientific Committee. Bernet V, Hupart KH, Parangi S and Woeber KA
Molecular Diagnostic Testing of Thyroid Nodules with Indeterminate Cytopathology Summary Highlights Writing Group for the AACE Thyroid Scientific Committee Bernet V, Hupart KH, Parangi S and Woeber KA
16.30 Kaposi s Sarcoma (KS): an interesting model for studying clinico-pathological relationship in tumorigenesis events
VIII th M.O.M.T. MEDITERRANEAN CONGRESS ON ONCOLOGICAL PATHOLOGY GALLIPOLI (LE) October 2015, 9-10 Convention Center - Grand Hotel Costa Brada Gallipoli (LE), ITALY 1 st day, Friday, October 2015, 9 8.30
Resolving Cancer Heterogeneity:
INTERNATIONAL SYMPOSIUM ON: Resolving Cancer Heterogeneity: The way to personalised medicine Palazzo della Gran Guardia Verona (Italy), June 30 th July 2 nd, 2016 PROGRAM Organized by: ARC-Net Centre for
European Federation of Cytology Societies 4th Annual Tutorial in Cytopathology Trieste, Italy Monday 6th to Friday 10th June 2011
European Federation of Cytology Societies 4th Annual Tutorial in Cytopathology Trieste, Italy Monday 6th to Friday 10th June 2011 This residential tutorial consists of lectures and microscope slidebased
Name of Policy: Molecular Markers in Fine Needle Aspirates of the Thyroid
Name of Policy: Molecular Markers in Fine Needle Aspirates of the Thyroid Policy #: 516 Latest Review Date: June 2015 Category: Laboratory Policy Grade: B Background/Definitions: As a general rule, benefits
International symposium on: The Impact of Genomic Deep Sequencing on
Bologna (Italy), 19 th and 20 th November, 2015 International symposium on: The Impact of Genomic Deep Sequencing on Paediatric Research and Clinical Practice Organized by Paediatrics Unit Sant Orsola
Title: Detection of erbb2 copy number variations in plasma of patients with esophageal carcinoma.
Author's response to reviews Title: Detection of erbb2 copy number variations in plasma of patients with esophageal carcinoma. Authors: Immacolata Andolfo ([email protected]) Giuseppe Petrosino ([email protected])
Molecular Pathogenesis of Thyroid Cancer
Introduction Thyroid cancer is the fastest growing cancer diagnosis in the US [1, 2] with a total of 44,670 new cases and 1,690 deaths expected in 2010 (www.cancer.gov/cancertopics/types/thyroid). From
Programme. Michele Grieco Dipartimento di Scienze Ambientali Seconda Università degli Studi di Napoli Naples, Italy
Programme Invited Speakers: Reuven Agami (The Netherlands), Manuela Baccarini (Austria), Allan Balmain (USA), Daniel Birnbaum (France), Anne-Lise Børresen-Dale (Norway), Carlos Caldas (UK), Silvana Canevari
Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers. Mont Ste. Odile, Alsace, France 11-14 September 2008
33 rd European Symposium on Hormones and Cell Regulation Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers Mont Ste. Odile, Alsace, France 11-14 September 2008 Invited Speakers:
Complex Systems BioMedicine: Molecules, Signals, Networks, Diseases
The International School of Advanced Molecular BioMedicine Complex Systems BioMedicine: Molecules, Signals, Networks, Diseases AciTrezza (Catania), Italy, October 2nd-6th, 2009 Hieronymus Bosch: Garden
LEGENDA. -23 th, 2015 EuROPEAN CONGRESS Of CYtOLOGY. MILAN, SEPtEMbER 20. Preliminary Program at a Glance 20 th September.
-23, 2015 Preliminary Program at a Glance 20 September Plenary RED 1+2 Blue 1 Blue 2 Yellow 1 Yellow 2 Yellow 3 8.30-11.30 11.30-12.30 QUATE EXAM IAC Annual General Meeting 12.30-14.30 Registration Registration
POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): 4/1/2015 Most Recent Review Date (Revised): 11/24/2015 Effective Date: 2/1/2016 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS
Interferon Fundamentals 2014
From Molecular Mechanisms to Human Diseases Rome, Auditorium Pocchiari Istituto Superiore di Sanità Over the last two decades, we have witnessed a tremendous progress in understanding the mechanisms by
D. N. Poller and S. Glaysher
DOI:10.1111/cyt.12109 BRAF V600 co-testing is technically feasible in conventional thyroid fine needle aspiration (FNA) cytology smears and can reduce the need for completion thyroidectomy Department of
BIOCHIP DEVELOPMENT FOR CANCER DIAGNOSIS Paradigmatic model of integration between knowledge and methodology
Ministero dell'istruzione dell Università e della Ricerca International Congress PROGETTO FIRB 2003 RBLA03S4SP NANOSIZED CANCER POLYMARKER BIOCHIP BIOCHIP DEVELOPMENT FOR CANCER DIAGNOSIS Paradigmatic
The following information is only meant for people who have been diagnosed with advanced non-small cell
Important information for people with advanced non-small cell lung cancer The following information is only meant for people who have been diagnosed with advanced non-small cell lung cancer (NSCLC). NSCLC
Florence November 6-7, 2015. International Meeting of Computer Aided Implantology Academy PROGRAM. X Annual Meeting
Aesculapius Colloquium Florence November 6-7, 2015 International Meeting of Computer Aided Implantology Academy X Annual Meeting PROGRAM International Meeting of Computer Aided Implantology Academy Friday,
Gruppi di lavoro Biologia Cellulare e Molecolare Biotecnologie e Differenziamento. Università degli Studi di Napoli Federico II BIOGEM.
Società Botanica Italiana Gruppi di lavoro Biologia Cellulare e Molecolare Biotecnologie e Differenziamento Università degli Studi di Napoli Federico II BIOGEM Organize the Summer School Challenges, methods
Course Structure 2015/2016
Master of Science in Business Administration UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA Course Structure 2015/2016 Management SSD CFU Service Management SECS P/08 6 Control and Auditing SSD CFU Marketing
The Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens
Breast Pathology Masterclass 2016
ALMA MATER STUDIORUM UNIVERSITà DI BOLOGNA DIpARTIMENTO di scienze BIOMEDIche e neuromotorie Nottingham Bologna Breast Pathology Masterclass 2016 Bologna (Italy) 21 st - 22 nd April 2016 Relais Bellaria
Alì Giuseppe [email protected] Dept of Physics, University of Calabria, Rende (CS), Italy.
Alì Giuseppe [email protected] Dept of Physics, University of Calabria, Rende (CS),. Al-Sulaimi Bushra [email protected] Mathematical Sciences Department, Durham University, UK Arima Takashi
Molecular Markers in Fine Needle Aspirates of the Thyroid
Molecular Markers in Fine Needle Aspirates of the Thyroid Policy Number: 2.04.78 Last Review: 3/2015 Origination: 3/2013 Next Review: 3/2016 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will
Mediterranean School of Oncology
Mediterranean School of Oncology Organized and supported by: CINBO Consorzio Interuniversitario Nazionale per la Bioncologia HIGHLIGHTS IN THE MANAGEMENT OF COLORECTAL CANCER, February 1-2, 2007 Domus
Molecular Diagnostics in Thyroid Cancer
Disclosure Nothing to disclose Jonathan George, MD, MPH Assistant Professor Head and Neck Oncologic & Endocrine Surgery Molecular Diagnostics in Thyroid Cancer Current Practices & Future Trends UCSF Medical
National Workshop of Hematology The TP53 Workshop
PRELIMINARY PROGRAMME National Workshop of Hematology The TP53 Workshop Bologna, 10 th May 2013 Aemilia Hotel Via G. Zaccherini Alvisi, 16 Bologna PROMOTED BY Workshop Presidents Michele Cavo Giovanni
Worldwide Collaborations in Molecular Profiling
Worldwide Collaborations in Molecular Profiling Lillian L. Siu, MD Director, Phase I Program and Cancer Genomics Program Princess Margaret Cancer Centre Lillian Siu, MD Contracted Research: Novartis, Pfizer,
Conflict of Interest. Overdiagnosis. Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates 4/17/2015. Jeffrey F.
Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates Jeffrey F. Krane, MD PhD Associate Professor of Pathology Harvard Medical School Chief, Head and Neck Pathology Service Associate Director,
The Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.
Where does Molecular Analysis of FNA Specimens fit into the evaluation of thyroid nodules? The Role of Genetic Testing in the Evaluation of Thyroid Nodules Ultrasound TSH Risk factors Jill E. Langer, MD
Kevin H. Hsu, MS, DO, Corrado Minimo MD, Seth Zwillenberg, MD
A Patient with Synchronous Follicular (Hurthle Cell), Papillary, and Medullary Thyroid Carcinomas: A Case Report with Literature Review on Possible Incidence and Pathogenesis Kevin H. Hsu, MS, DO, Corrado
National Workshop of Hematology The TP53 Workshop
National Workshop of Hematology The TP53 Workshop Bologna, 10 th May 2013 Aemilia Hotel Via G. Zaccherini Alvisi, 16 Bologna PROMOTED BY Workshop Presidents Michele Cavo Giovanni Martinelli Pier Luigi
GENETICS AND GENOMICS OF THYROID NEOPLASMS MOVING CLOSER TOWARDS PERSONALIZED PATIENT CARE
Genomics in Medicine Series GENETICS AND GENOMICS OF THYROID NEOPLASMS MOVING CLOSER TOWARDS PERSONALIZED PATIENT CARE Electron Kebebew, MD, FACS Outline To assess the change in thyroid cancer epidemiology
MOLECULAR REFLEX TESTING OF THYROID FNA
MOLECULAR REFLEX TESTING OF THYROID FNA Yuri E. Nikiforov, M.D., Ph.D. Division of Molecular Anatomic Pathology University of Pittsburgh School of Medicine FNA cytology is the most reliable diagnostic
PRELIMINARY PROGRAMME I ACT. Bologna, 30 th November - 1 st December. Aula Chiantore
PRELIMINARY PROGRAMME I ACT Bologna, 30 th November - 1 st December 2012 Aula Chiantore Institute of Hematology L. e A. Seràgnoli Sant Orsola - Malpighi University Hospital PAV. 8 PROMOTED BY SCIENTIFIC
UNIVERSITÀ DEGLI STUDI DI BARI ALDO MORO, ITALY OFFICIAL ANNOUNCEMENT CALL FOR APPLICATION
ANNEX 4 (Allegato 4) UNIVERSITÀ DEGLI STUDI DI BARI ALDO MORO, ITALY OFFICIAL ANNOUNCEMENT CALL FOR APPLICATION SCHOOL OF ADVANCED STUDIES IN LAW ( SCUOLA DI DOTTORATO IN DIRITTO ) SCHOOL OF ADVANCED STUDIES
KNOWLEDGE MANAGEMENT TRACKS
Hi, take the opportunity to participate as a speaker by call for papers / sponsor in KNOWLEDGE MANAGEMENT TRACKS, the 19 th edition of a conference on infrastructures and applications on managing and communicating
BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls?
BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls? Giovanni Luca Scaglione, PhD ------------------------ Laboratory of Clinical Molecular Diagnostics and Personalized Medicine, Institute
Thyroid Fine-Needle Aspiration Indications and Technique. Subcommittee members Zubair W. Baloch, MD, PhD Martha Bishop Pitman, MD
Thyroid Fine-Needle Aspiration Indications and Technique Subcommittee members Zubair W. Baloch, MD, PhD Martha Bishop Pitman, MD Thyroid FNA Indication Clinical Thyroid Nodule (s) > 1 cm? Hypo-functioning
Breast cancer research and a changing treatment pathway
Breast cancer research and a changing treatment pathway Stuart McIntosh Clinical Senior Lecturer in Surgical Oncology, QUB Consultant Breast Surgeon, BCH What is the breast surgeon s role in 2016? Surgery
New Frontiers. in Glaucoma. Management. Rome, 7 February 2014 Donna Camilla Savelli Hotel
New Frontiers in Glaucoma Management Rome, 7 February 2014 Donna Camilla Savelli Hotel FACULTY Marco Centofanti University of Rome Tor Vergata Head of Glaucoma Research Line IRCCS - Fondazione Bietti Rome
Clinical Use of Molecular Diagnos@cs in the Treatment of Lung Cancer
Clinical Use of Molecular Diagnos@cs in the Treatment of Lung Cancer Tianhong Tina Li, MD, PhD ([email protected]) Associate Professor of Clinical Medicine, School of Medicine Disclosures Grants/Research
Nuovi Scenari in Oncologia. G. Zoppoli X-Files in Nutrizione Clinica e Artificiale, 08/06/2012
Nuovi Scenari in Oncologia G. Zoppoli X-Files in Nutrizione Clinica e Artificiale, 08/06/2012 WHAT is cancer? «Cancer is a genetic disease of the somatic cell» [B. Vogelstein] Ten years ago Now [Cell.
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer Part of NCI s Precision Medicine Effort in
targeted therapy a guide for the patient
targeted therapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2-3 Gene changes... 4-5 Testing... 7-8 Targeted therapy... 9-11 Drugs Targeting EGFR... 12 Drugs Targeting
Médecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN
Médecine de précision médecine personnalisée en Oncologie Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN Successful targeted drug development Rapid identification
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom Luca Gianni Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy Ana Maria Gonzalez-Angulo M.D. Anderson Cancer
How To Become A Professor In Italy
UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II PHD PROGRAMS 31 st CYCLE ACADEMIC YEAR 2015/2016 List of the PhD Programs with reserved positions PhD Program in BIOLOGY Positions: No. 14 Student grants: No.
Curriculum Vitae. Personal information Name: Anna Surname: Puggina Date of Birth: 24/01/1987 Place of Birth: Dolo (VE), Italy Citizenship: Italian
Curriculum Vitae Personal information Name: Anna Surname: Puggina Date of Birth: 24/01/1987 Place of Birth: Dolo (VE), Italy Citizenship: Italian Contact information Address: Via San Pio X 7/a, 35122,
Departamento de Economía Universidad Carlos III Tel. +34-91-624 9546 Calle Madrid 126 Fax +34-91-624 9875. http://www.eco.uc3m.
MARCO CELENTANI Departamento de Economía Universidad Carlos III Tel. +34-91-624 9546 Calle Madrid 126 Fax +34-91-624 9875 Getafe (Madrid) 28903 [email protected] Spain http://www.eco.uc3m.es/celentani/
Surgical Perspective of T1799A BRAF Mutation Diagnostic Value in Papillary Thyroid Carcinoma
DOI:http://dx.doi.org/10.7314/APJCP.2013.14.1.31 RESEARCH ARTICLE Surgical Perspective of T1799A BRAF Mutation Diagnostic Value in Papillary Thyroid Carcinoma Bayu Brahma 1 *, Erwin Danil Yulian 2, Muchlis
BEYOND THE SLIDES 2015 1 st UDINE ECMO WORKSHOP
BEYOND THE SLIDES 2015 1 st UDINE ECMO WORKSHOP DECEMBER 18-19, 2015 AUDITORIUM HYPO ALPE ADRIA TAVAGNACCO (UD) PROMOTED BY CARDIOTHORACIC DEPARTMENT SUPPORTED BY Under the auspices of With the patronage
Revision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices. Response from Cancer Research UK to the Commission August 2010
Revision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices Response from Cancer Research UK to the Commission August 2010 1. Cancer Research UK (CR-UK) 1 is leading the world in finding
Interdisciplinary courses. Courses lecturers Schedule/lecturer. Prof. Maurizio Consoli (INFN) Prof. Mauro Dorato (University Roma Tre)
Planned courses for the academic year 2014/2015 Interdisciplinary courses Courses lecturers Schedule/lecturer Prof. Maurizio Consoli (INFN) Space, Time and Vacuum in Scientific and Philosophical Thought
BREAST CANCER IN YOUNG WOMEN. OCTOBER 9 th 2015 Aula Magna UNIVERSITÀ DELLA SVIZZERA ITALIANA Lugano
Centro di Senologia della Svizzera Italiana 8 th Edition BREAST CANCER IN YOUNG WOMEN OCTOBER 9 th Aula Magna UNIVERSITÀ DELLA SVIZZERA ITALIANA Lugano Scientific Coordinators: Olivia Pagani and Alberto
Roche Diagnostics Driving Personalized Healthcare
r his presentation contains certain forward-looking statements. hese forward-looking statements may be identified by words such as believes, expects, anticipates, projects, intends, should, seeks, estimates,
Magic-5. Medical Applications in a GRID Infrastructure Connection. Ivan De Mitri* on behalf of MAGIC-5 collaboration
Magic-5 Medical Applications in a GRID Infrastructure Connection Ivan De Mitri* on behalf of MAGIC-5 collaboration *Dipartimento di Fisica dell Università di Lecce and Istituto Nazionale di Fisica Nucleare,
150 th Course Geriatrics, Molecular and Clinical Oncology: an Overwiew
University of Palermo School of Medicine Ettore Majorana Foundation and Centre for Scientific Culture INTERNATIONAL SCHOOL OF MEDICINE Director of the School: A. Zichichi 150 th Course Geriatrics, Molecular
Targeted Therapies in Lung Cancer
Targeted Therapies in Lung Cancer I Edited by: Simona Carnio Thoracic Oncology Division - St Luigi Hospital Orbassano (TO) - Italy Silvia Novello Department of Oncology - University of Torino - Italy Why
PRELIMINARY PROGRAMME I ACT. Bologna, 30 th November - 1 st December. Aula Chiantore
PRELIMINARY PROGRAMME I ACT Bologna, 30 th November - 1 st December 2012 Aula Chiantore Institute of Hematology L. e A. Seràgnoli Sant Orsola - Malpighi University Hospital PAV. 8 PROMOTED BY SCIENTIFIC
Supplementary Table 1. ILTE centers, patients, and PCR assays*
Supplementary Table 1. ILTE centers, patients, and PCR assays* Center PI/Co-PI No. registered patients No. eligibile patients () Type of PCR 1 University of Milano Bicocca, Monza - Italy Carlo Gambacorti-Passerini,
Applications of comprehensive clinical genomic analysis in solid tumors: obstacles and opportunities
Applications of comprehensive clinical genomic analysis in solid tumors: obstacles and opportunities Vincent A. Miller, M.D. Foundation Medicine, Inc. AACR Annual Meeting 2012 Current Concepts session
The Faculty of Engineering and Architecture of th e University of Enna Kore The Degree Course in Aerospace Engineering. in collaboration with
The Faculty of Engineering and Architecture of th e University of Enna Kore The Degree Course in Aerospace Engineering in collaboration with The department of Aerospace Engineering of the University of
The cooperative enterprise between national taxation and the european market
The cooperative enterprise between national taxation and the european market 11-12 September 2008 ww.euricse.eu with the patronage of International Seminar The cooperative enterprise between national taxation
From Objects to Agents
Matteo Baldoni, Cristina Baroglio Federico Bergenti, Alfredo Garro (eds.) From Objects to Agents XIV Workshop, WOA 2013 Torino, Italy, December 2nd-3rd, 2013 Workshop Notes WOA 2013 Home Page: http://di.unito.it/woa2013
workshop The challenge of Bio-districts during the 2014-2020 programming period
Welcome and opening: Andrea Ferrante AIAB Francesco Giardina Ministry of Agriculture Alessandra Terrosi Chamber of Deputies - Committee on Agriculture Interventions: Livio Martini - President of the Bio-district
Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America
Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions
Workshop: La Medicina Telematica per la disabilità è una realtà: chi, dove e quando. Esperienze di teledermatologia a Modena
Workshop: La Medicina Telematica per la disabilità è una realtà: chi, dove e quando. Esperienze di teledermatologia a Modena Prof. Alberto Giannetti Direttore Istituto Dermatologia - Università degli Studi
SMART CITY CHALLENGES : PLANNING FOR SMART CITIES. DEALING WITH NEW URBAN CHALLENGES
SMART CITY CHALLENGES : PLANNING FOR SMART CITIES. DEALING WITH NEW URBAN CHALLENGES 3 (2014) Published by Laboratory Land Use Mobility and Environment DICEA - Department Civil, Architectural and Environmental
Provincia di Foggia Comune di Foggia
under the patronage of Provincia di Foggia Comune di Foggia Dear Students With a great pleasure that in cooperation with the degree course in Dentistry, the AISO (Italian Dental Student Association) and
Student Details. Student ID e155078 Date of Birth 10/02/1989 Place of Birth INDIA Nationality Italian. Education. Turin. Berlin
Student ID e155078 Date of Birth 10/02/1989 Place of Birth INDIA Università degli studi di Torino Berlin Student ID e155170 Date of Birth 21/09/1986 Place of Birth NAPOLI Università degli Studi di Napoli
Thyroid FNA Ancillary Studies. Douglas P. Clark, M.D. Zubair W. Baloch, M.D., Ph.D.
Thyroid FNA Ancillary Studies Douglas P. Clark, M.D. Zubair W. Baloch, M.D., Ph.D. What are the goals of ancillary studies of thyroid FNAs? Characterization of a known malignancy (
